Scholarlink

<p>Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and due to the lack of robust therapeutic targets, treatment options remain limited to conventional cytotoxic chemotherapy and surgical resection. Autophagy, a lysosome-dependent degradation process, is typically regarded as a survival mechanism. However, excessive degradation of ferritin may indirectly lead to Fe²⁺ accumulation, thereby facilitating ferroptosis. In this study, we reveal for the first time the existence of a TRIM39-RNF168 ubiquitination axis in the TNBC model that targets autophagy-dependent ferroptosis in TNBC cells. The high expression of TRIM39 in TNBC cells confers resistance to ferroptosis and enhances cell survival. Regulation of the TRIM39-RNF168 axis, achieved by knocking down TRIM39 or RNF168, can activate autophagy-coupled ferroptosis in TNBC cells. The activated autophagy-ferroptosis pathway effectively suppresses TNBC progression in vivo, presenting a promising potential therapeutic approach.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

TRIM39-mediated deubiquitination upregulates RNF168 to evade autophagy-ferroptosis in triple-negative breast cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月1日

查看全文
  • Xiaoli Yao,
  • Xiong Shen,
  • Yue Fan,
  • Hong Wang

摘要

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and due to the lack of robust therapeutic targets, treatment options remain limited to conventional cytotoxic chemotherapy and surgical resection. Autophagy, a lysosome-dependent degradation process, is typically regarded as a survival mechanism. However, excessive degradation of ferritin may indirectly lead to Fe²⁺ accumulation, thereby facilitating ferroptosis. In this study, we reveal for the first time the existence of a TRIM39-RNF168 ubiquitination axis in the TNBC model that targets autophagy-dependent ferroptosis in TNBC cells. The high expression of TRIM39 in TNBC cells confers resistance to ferroptosis and enhances cell survival. Regulation of the TRIM39-RNF168 axis, achieved by knocking down TRIM39 or RNF168, can activate autophagy-coupled ferroptosis in TNBC cells. The activated autophagy-ferroptosis pathway effectively suppresses TNBC progression in vivo, presenting a promising potential therapeutic approach.